62 results on '"Tay, Edgar"'
Search Results
2. Bayesian Meta-analysis of Direct Oral Anticoagulation Versus Vitamin K Antagonists With or Without Concomitant Antiplatelet After Transcatheter Aortic Valve Implantation in Patients With Anticoagulation Indication.
- Author
-
Lee, Gabriel Sheng Jie, Tay, Hannah Si En, Teo, Vanessa Xin Yi, Goh, Rachel Sze Jen, Chong, Bryan, Chan, Siew Pang, Tay, Edgar, Lim, Yinghao, Yip, James, Chew, Nicholas W. S, and Kuntjoro, Ivandito
- Subjects
HEART valve prosthesis implantation ,META-analysis ,MEDICAL information storage & retrieval systems ,COMBINATION drug therapy ,SYSTEMATIC reviews ,ANTICOAGULANTS ,TREATMENT effectiveness ,COMPARATIVE studies ,PLATELET aggregation inhibitors ,DESCRIPTIVE statistics ,MEDLINE ,ODDS ratio ,COMORBIDITY ,VITAMIN K - Abstract
Patients undergoing transcatheter aortic valve implantation (TAVI) commonly have co-morbidities requiring anticoagulation. However, the optimal post-procedural anticoagulation regimen is not well-established. This meta-analysis investigates safety and efficacy outcomes of direct oral anticoagulants (DOACs) and Vitamin K Antagonist (VKA), with or without concomitant antiplatelet therapy. We searched EMBASE and MEDLINE for appropriate studies. Subgroup analyses were performed for anticoagulant monotherapy and combined therapy with antiplatelet agents. Eleven studies (6359 patients) were included. Overall, there were no differences between DOACs and VKA for all-cause mortality (Odds Ratio [OR]:.69; Credible Interval [CrI]:.40–1.06), cardiovascular-related mortality (OR:.76; Crl:.13–3.47), bleeding (OR:.95; CrI:.75–1.17), stroke (OR: 1.04; CrI:.65–1.63), myocardial infarction (OR: 1.51; CrI:.55–3.84), and valve thrombosis (OR:.29; CrI:.01–3.54). For DOACs vs VKA monotherapy subgroup, there were no differences in outcomes. For the combined therapy subgroup, there was decreased odds of all-cause mortality in the DOACs group compared with the VKA group (OR:.13; CrI:.02–.65), but no differences for bleeding and stroke. DOACs and VKA have similar safety and efficacy profiles for post-TAVI patients with anticoagulation indication. However, if concomitant antiplatelet therapy is required, DOACs were more favorable than VKA for all-cause mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. First use of large-bore suction thrombectomy for acute pulmonary embolism in Asia-Pacific: feasibility and short-term clinical outcomes.
- Author
-
Kojodjojo, Pipin, Ong, Hean Ann, Loh, Poay Huan, Tay, Edgar, Chang, Peter, Kuntjoro, Ivandito, Low, Ting Ting, and Lim, Yinghao
- Abstract
Clinical outcomes for intermediate or high-risk pulmonary emboli (PE) remain sub-optimal, with limited improvements in survival for the past 15 years. Anticoagulation alone results in slow thrombus resolution, persistent right ventricular (RV) dysfunction, patients remaining at risk of haemodynamic decompensation and increased likelihood of incomplete recovery. Thrombolysis elevates risk of major bleeding and is thus reserved for high-risk PE. Thus, a huge clinical need exists for an effective technique to restore pulmonary perfusion with minimal risk and avoidance of lytic therapy. In 2021, large bore suction thrombectomy (ST) was introduced in Asia for the first time and this study assessed the feasibility and short-term outcomes of Asian patients undergoing ST for acute PE. 40 consecutive patients (58% male, mean age of 58.3 ± 16.6 years) with intermediate (87.5%) or high-risk PE (12.5%) were enrolled in this prospective registry. 20% had prior VTE, 42.5% had contraindications to thrombolysis, and 10% failed to respond to thrombolysis. PE was idiopathic in 40%, associated with active cancer in 15% and post-operative status in 12.5%. Procedural time was 124 ± 30 min. Emboli were aspirated in all patients without the need for thrombolytics, resulting in a 21.4% reduction in mean pulmonary arterial pressures and 123% increase TASPE-PASP ratio, a prognostic measure of RV-arterial coupling. (both p < 0.001) Procedural complications were 5% and 87.5% patients survived to discharge without symptomatic VTE recurrence during 184 days of mean follow-up. ST affords an effective reperfusion option for PE without thrombolytics, normalises RV overload and provides excellent short-term clinical outcomes. Key points: Large bore suction thrombectomy is an effective minimally invasive reperfusion therapy for patients with intermediate or high-risk pulmonary embolism (PE), without the use of thrombolytics. Significant reductions in mean pulmonary arterial pressures and heart rates were achieved, resulting in normalisation of right ventricular (RV) strain, size and improvement in RV-pulmonary arterial coupling and stroke volumes. 95% of PE patients who did not require cardiopulmonary resuscitation, survived to discharge without VTE recurrence during 184 days of mean follow-up. Ongoing multi-centre randomized controlled trials comparing suction thrombectomy to routine care will confirm the benefits of early catheter-based reperfusion therapy for PE. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus.
- Author
-
Dimopoulos, Konstantinos, Constantine, Andrew, Clift, Paul BA, Condliffe, Robin, Moledina, Shahin, Jansen, Katrijn, Inuzuka, Ryo, Veldtman, Gruschen R., Cua, Clifford L., Tay, Edgar Lik Wui MMed, Opotowsky, Alexander R. M, Giannakoulas, George, Alonso-Gonzalez, Rafael, Cordina, Rachael, Capone, George, Namuyonga, Judith MMed, Scott, Charmaine H. OD, c, DCH, DM(Paeds), D'Alto, Michele, Gamero, Francisco J., and Chicoine, Brian
- Published
- 2023
- Full Text
- View/download PDF
5. Clinical outcomes of severe tricuspid valve infective endocarditis related to intravenous drug abuse – a case series.
- Author
-
Chong, Cheryl Zhiya, Cherian, Robin, Ng, Perryn, Yeo, Tiong Cheng, Ling, Lieng Hsi, Soo, Wern Miin, Wong, Raymond Ching Chiew, Tambyah, Paul Anantharajah, Kong, William Kok-Fai, and Tay, Edgar Lik Wui
- Subjects
INFECTIVE endocarditis ,INTRAVENOUS drug abuse ,TRICUSPID valve ,DISSEMINATED intravascular coagulation ,TREATMENT effectiveness ,ATRIAL fibrillation - Abstract
Right-sided infective endocarditis (IE) related to intravenous drug use (IVDU) can follow an acute fulminant course. However, there is limited information on its longer-term clinical outcomes. We assessed a cohort of consecutive patients who presented with IVDU complicated by severe tricuspid valve regurgitation to determine their presentation, treatment, and long-term outcomes. In this study, severe tricuspid regurgitation (TR) was defined by the European Association of Cardiovascular Imaging criteria at initial presentation to the hospital. Thirty-three patients with a mean age of 35 ± 18 years (72% males) presented with IVDU associated with severe TR. At the initial presentation, 15 patients were in septic shock and required inotropes. 26 patients had septic pulmonary emboli; 10 patients had associated metastatic systemic sites of infection of which 5 patients had central nervous system (CNS) involvement. Three patients were in disseminated intravascular coagulation (DIC) and 1 patient had multi-organ failure (MOF), but not requiring dialysis or mechanical ventilation. Most patients had large tricuspid valve vegetations of >20mm. Eleven patients underwent surgery with 18% perioperative mortality. The Median follow-up was 6.4 years (0.5–11.4). Recurrent IE occurred in one-third of patients, the overall incidence of heart failure and Atrial fibrillation (AF) on follow-up was low in all 3 groups. Five-year survival was 94%. Acute severe TR following associated endocarditis IVDU results in a fulminant initial presentation, but a longer-term prognosis is good with surgical and medical treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Left ventricular remodelling in bicuspid aortic valve disease.
- Author
-
Butcher, Steele C, Pio, Stephan M, Kong, William K F, Singh, Gurpreet K, Ng, Arnold C T, Perry, Rebecca, Sia, Ching-Hui, Poh, Kian Keong, Almeida, Ana G, González, Ariana, Shen, Mylène, Yeo, Tiong Cheng, Shanks, Miriam, Popescu, Bogdan A, Gay, Laura Galian, Fijałkowski, Marcin, Liang, Michael, Tay, Edgar, Marsan, Nina Ajmone, and Selvanayagam, Joseph
- Subjects
RESEARCH ,REPORTING of diseases ,CONFIDENCE intervals ,VENTRICULAR remodeling ,CONGENITAL heart disease ,ACQUISITION of data ,MEDICAL records ,DESCRIPTIVE statistics ,AORTIC valve diseases ,SYMPTOMS - Abstract
Aims Characterization of left ventricular (LV) geometric pattern and LV mass could provide an important insight into the pathophysiological adaptations of the LV to pressure and/or volume overload in patients with bicuspid aortic valve (BAV) and significant (≥moderate) aortic valve (AV) disease. This study aimed to characterize LV remodelling and its prognostic impact in patients with BAV according to the predominant type of valvular dysfunction. Methods and results In this international, multicentre BAV registry, 1345 patients [51.0 (37.0–63.0) years, 71% male] with significant AV disease were identified. Patients were classified as having isolated aortic stenosis (AS) (n = 669), isolated aortic regurgitation (AR) (n = 499) or mixed aortic valve disease (MAVD) (n = 177). LV hypertrophy was defined as a LV mass index >115 g/m
2 in males and >95 g/m2 in females. LV geometric pattern was classified as (i) normal geometry: no LV hypertrophy, relative wall thickness (RWT) ≤0.42, (ii) concentric remodelling: no LV hypertrophy, RWT >0.42, (iii) concentric hypertrophy: LV hypertrophy, RWT >0.42, and (iv) eccentric hypertrophy: LV hypertrophy, RWT ≤0.42. Patients were followed-up for the endpoints of event-free survival (defined as a composite of AV repair/replacement and all-cause mortality) and all-cause mortality. Type of AV dysfunction was related to significant variations in LV remodelling. Higher LV mass index, i.e. LV hypertrophy, was independently associated with the composite endpoint for patients with isolated AS [hazard ratio (HR) 1.08 per 25 g/m2 , 95% confidence interval (CI) 1.00–1.17, P = 0.046] and AR (HR 1.19 per 25 g/m2 , 95% CI 1.11–1.29, P < 0.001), but not for those with MAVD. The presence of concentric remodelling, concentric hypertrophy and eccentric hypertrophy were independently related to the composite endpoint in patients with isolated AS (HR 1.54, 95% CI 1.06–2.23, P = 0.024; HR 1.68, 95% CI 1.17–2.42, P = 0.005; HR 1.59, 95% CI 1.03–2.45, P = 0.038, respectively), while concentric hypertrophy and eccentric hypertrophy were independently associated with the combined endpoint for those with isolated AR (HR 2.49, 95% CI 1.35–4.60, P = 0.004 and HR 3.05, 95% CI 1.71–5.45, P < 0.001, respectively). There was no independent association observed between LV remodelling and the combined endpoint for patients with MAVD. Conclusions LV hypertrophy or remodelling were independently associated with the composite endpoint of AV repair/replacement and all-cause mortality for patients with isolated AS and isolated AR, although not for patients with MAVD. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
7. Chronic thromboembolic pulmonary hypertension: a review.
- Author
-
Zhiya Chong, Cheryl, Lik Wui Tay, Edgar, Ching Hui Sia, Kian Keong Poh, Chong, Cheryl Zhiya, Tay, Edgar Lik Wui, Sia, Ching Hui, and Poh, Kian Keong
- Subjects
PULMONARY hypertension ,THROMBOEMBOLISM ,ENDOTHELIN receptors ,GUANYLATE cyclase ,TRANSLUMINAL angioplasty ,PULMONARY hypertension treatment ,PULMONARY embolism ,CHRONIC diseases ,PULMONARY artery ,ENDARTERECTOMY ,DISEASE complications - Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary hypertension resulting from obstruction of the pulmonary artery by fibrotic thromboembolic material, usually initiated by recurrent or incomplete resolution of pulmonary embolism. This distinct form of pulmonary hypertension is classified under Group 4 of the World Health Organization classification. Further investigations are usually initiated, with transthoracic echocardiography followed by right heart catheterisation and pulmonary angiography as the gold standard. Definitive treatment is usually in the form of surgical pulmonary endarterectomy. Inoperable CTEPH is medically treated with pharmacological agents such as phosphodiesterase Type 5 inhibitors, endothelin receptor antagonists, soluble guanylate cyclase stimulators and prostacyclin. Recent developments have made balloon pulmonary angioplasty a viable option as well. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Novel predictive role for mid-regional proadrenomedullin in moderate to severe aortic stenosis.
- Author
-
Tan, Eugene S. J., Yen Yee Oon, Siew Pang Chan, Oi Wah Liew, Chong, Jenny P. C., Tay, Edgar, Wern Miin Soo, Yip, James W. L., Gong, Lingli, Lunaria, Josephine B., Quek Wei Yong, Min Lee, Evelyn, Yeo, Daniel P. S., Zee Pin Ding, Hak Chiaw Tang, See Hooi Ewe, Chin, Calvin C. W., Siang Chew Chai, A. Mark, Ping Ping Goh, and Lee Fong Ling
- Subjects
LEFT heart ventricle ,RESEARCH ,RESEARCH methodology ,AORTIC stenosis ,PROTEIN precursors ,PROGNOSIS ,EVALUATION research ,ATRIAL natriuretic peptides ,COMPARATIVE studies ,STROKE volume (Cardiac output) ,PEPTIDE hormones ,HEART physiology ,HEART failure ,PEPTIDES - Abstract
Objective: We investigated the prognostic significance of selected known and novel circulating biomarkers in aortic stenosis (AS).Methods: N-terminal pro-BNP (NT-proBNP), high-sensitivity troponin-T (hsTnT), growth differentiation factor-15 (GDF-15), suppression of tumorigenicity-2 (ST2), mid-regional proadrenomedullin (MR-proADM) and mid-regional proatrial natriuretic peptide (MR-proANP) were measured in patients with moderate to severe AS, New York Heart Association (NYHA) class I-II and left ventricular ejection fraction ≥50%, recruited consecutively across five centres from 2011 to 2018. Their ability to predict both primary (all-cause mortality, heart failure hospitalisation or progression to NYHA class III-IV) and secondary (additionally incorporating syncope and acute coronary syndrome) outcomes was determined by competing risk analyses.Results: Among 173 patients with AS (age 69±11 years, 55% male, peak transaortic velocity (Vmax) 4.0±0.8 m/s), the primary and secondary outcomes occurred in 59 (34%) and 66 (38%), respectively. With aortic valve replacement as a competing risk, the primary outcome was determined consistently by the comorbidity index and each selected biomarker except ST2 (p<0.05), independent of NYHA class, Vmax, LV-global longitudinal strain and serum creatinine. MR-proADM had the highest discriminative value for both primary (subdistribution HR (SHR) 11.3, 95% CI 3.9 to 32.7) and secondary outcomes (SHR 12.6, 95% CI 4.7 to 33.5). Prognostic assessment of dual-biomarker combinations identified MR-proADM plus either hsTnT or NT-proBNP as the best predictive model for both clinical outcomes. Paired biomarker models were not superior to those including MR-proADM as the sole circulating biomarker.Conclusion: MR-proADM most powerfully portended worse prognosis and should be further assessed as possibly the biomarker of choice for risk stratification in AS. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
9. Validation of aortic valve calcium quantification thresholds measured by computed tomography in Asian patients with calcific aortic stenosis.
- Author
-
Guzzetti, Ezequiel, Oh, Jin Kyung, Shen, Mylène, Dweck, Marc R, Poh, Kian Keong, Abbas, Amr E, Mando, Ramy, Pressman, Gregg S, Brito, Daniel, Tastet, Lionel, Pawade, Tania, Falconi, Mariano Luis, Arenaza, Diego Perez de, Kong, William, Tay, Edgar, Pibarot, Philippe, Song, Jae-Kwan, and Clavel, Marie-Annick
- Subjects
REFERENCE values ,AORTIC stenosis ,CALCINOSIS ,DESCRIPTIVE statistics ,COMPUTED tomography ,HEMODYNAMICS ,ETHNIC groups ,AORTIC valve - Abstract
Aims Sex-specific thresholds of aortic valve calcification (AVC) have been proposed and validated in Caucasians. Thus, we aimed to validate their accuracy in Asians. Methods and results Patients with calcific aortic stenosis (AS) from seven international centres were included. Exclusion criteria were ≥moderate aortic/mitral regurgitation and bicuspid valve. Optimal AVC and AVC-density sex-specific thresholds for severe AS were obtained in concordant grading and normal flow patients (CG/NF). We included 1263 patients [728 (57%) Asians, 573 (45%) women, 837 (66%) with CG/NF]. Mean gradient was 48 (26–64) mmHg and peak aortic velocity 4.5 (3.4–5.1) m/s. Optimal AVC thresholds were: 2145 Agatston Units (AU) in men and 1301 AU in women for Asians; and 1885 AU in men and 1129 AU in women for Caucasians. Overall, accuracy (% correctly classified) was high and comparable either using optimal or guidelines' thresholds (2000 AU in men, 1200 AU in women). However, accuracy was lower in Asian women vs. Caucasian women (76–78% vs. 94–95%; P < 0.001). Accuracy of AVC-density (476 AU/cm
2 in men and 292 AU/cm2 in women) was comparable to absolute AVC in Caucasians (91% vs. 91%, respectively, P = 0.74), but higher than absolute AVC in Asians (87% vs. 81%, P < 0.001). There was no interaction between AVC/AVC-density and ethnicity (all P > 0.41) with regards to AS haemodynamic severity. Conclusion AVC thresholds defining severe AS are comparable in Asian and Caucasian populations, and similar to those proposed in the guidelines. However, accuracy of AVC to identify severe AS in Asians (especially women) is sub-optimal. Therefore, the use of AVC-density is preferable in Asians. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Prognostic implications of left atrial dilation in aortic regurgitation due to bicuspid aortic valve.
- Author
-
Butcher, Steele C., Fortuni, Federico, Kong, William, Vollema, E. Mara, Prevedello, Francesca, Perry, Rebecca, Chin Tse Ng, Arnold, Kian Keong Poh, Almeida, Ana G., González-Gómez, Ariana, Shen, Mylène, Tiong-Cheng Yeo, Shanks, Miriam, Popescu, Bogdan A., Galian-Gay, Laura, Fijalkowski, Marcin, Liang, Michael, Tay, Edgar, Marsan, Nina Ajmone, and Selvanayagam, Joseph B.
- Subjects
MITRAL valve ,AORTIC valve ,AORTIC valve insufficiency ,LEFT heart atrium ,PROGNOSIS ,HEART valve prosthesis implantation - Abstract
Objective: To investigate the prognostic value of left atrial volume index (LAVI) in patients with moderate to severe aortic regurgitation (AR) and bicuspid aortic valve (BAV).Methods: 554 individuals (45 (IQR 33-57) years, 80% male) with BAV and moderate or severe AR were selected from an international, multicentre registry. The association between LAVI and the combined endpoint of all-cause mortality or aortic valve surgery was investigated with Cox proportional hazard regression analyses.Results: Dilated LAVI was observed in 181 (32.7%) patients. The mean indexed aortic annulus, sinus of Valsalva, sinotubular junction and ascending aorta diameters were 13.0±2.0 mm/m2, 19.4±3.7 mm/m2, 16.5±3.8 mm/m2 and 20.4±4.5 mm/m2, respectively. After a median follow-up of 23 (4-82) months, 272 patients underwent aortic valve surgery (89%) or died (11%). When compared with patients with normal LAVI (<35 mL/m2), those with a dilated LAVI (≥35 mL/m2) had significantly higher rates of aortic valve surgery or mortality (43% and 60% vs 23% and 36%, at 1 and 5 years of follow-up, respectively, p<0.001). Dilated LAVI was independently associated with reduced event-free survival (HR=1.450, 95% CI 1.085 to 1.938, p=0.012) after adjustment for LV ejection fraction, aortic root diameter, LV end-diastolic diameter and LV end-systolic diameter.Conclusions: In this large, multicentre registry of patients with BAV and moderate to severe AR, left atrial dilation was independently associated with reduced event-free survival. The role of this parameter for the risk stratification of individuals with significant AR merits further investigation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
11. Does pulmonary artery pulsatility index predict mortality in pulmonary arterial hypertension?
- Author
-
Yinghao Lim, Ting-Ting Low, Siew Pang Chan, Weiqin Lin, Ting Wei Teo, Jin-Hao Justin Jang, Ivandito Kuntjoro, Lik-Wui Tay, Edgar, and Wei-Luen Yip, James
- Subjects
PULMONARY artery ,PULMONARY hypertension ,MORTALITY - Abstract
Aims Pulmonary artery pulsatility index (PAPi), defined as [(pulmonary artery systolic pressure ( diastolic pulmonary artery pressure)/mean right atrial pressure], is a novel haemodynamic index that predicts right ventricular failure after myocardial infarction and left ventricular assist device implantation. We analysed if a low PAPi is associated with death in our 14 - year pulmonary arterial hypertension (PAH) registry. Methods Consecutive patients with newly diagnosed PAH and complete haemodynamic data were prospectively enrolled into our standing registry between January 2003 and December 2016. PAPi was calculated from baseline invasive right heart catheterization data. A prognostic cut-off value was determined with a decision tree. Baseline characteristics of ‘high’ and ‘low’ PAPi groups based on this cut-off were compared, as well as odds of death and time-to-death. Results One hundred and two patients were included. Mean age was 53 years, and 77% were women. Our multi-ethnic cohort was 64% Chinese, 23% Malay, and 10% Indian. The aetiologies were idiopathic (33%), connective tissue disease (31%), congenital heart disease (24%), and others (12%). The low PAPi group (<5.3) had a greater age (56 years vs. 49 years), lower pulmonary artery systolic pressure (71 mmHg vs. 85 mmHg), and higher mean right atrial pressure (14 mmHg vs. 6 mmHg). Mortality risk was higher in the low PAPi group (adjusted odds ratio: 2.98 and adjusted hazard ratio: 2.23). Mean right atrial pressure was the strongest predictor (hazard ratio 1.114, P = 0.009) when components of PAPi were analysed. Conclusions Pulmonary artery pulsatility index was found to be predictive of mortality in PAH and may be a valuable marker for risk stratification. Its prognostic strength may be driven by mean right atrial pressure. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Predicting mortality, thrombus recurrence and persistence in patients with post-acute myocardial infarction left ventricular thrombus.
- Author
-
Yeung, Wesley, Sia, Ching-Hui, Pollard, Tom, Leow, Aloysius Sheng-Ting, Tan, Benjamin Yong-Qiang, Kaur, Rajinderdeep, Yeo, Tiong-Cheng, Tay, Edgar Lik-Wui, Yeo, Leonard Leong-Litt, Chan, Mark Yan-Yee, and Loh, Joshua Ping-Yun
- Abstract
Left ventricular thrombus (LVT) is a common complication of acute myocardial infarction and is associated with morbidity from embolic complications. Predicting which patients will develop death or persistent LVT despite anticoagulation may help clinicians identify high-risk patients. We developed a random forest (RF) model that predicts death or persistent LVT and evaluated its performance. This was a single-center retrospective cohort study in an academic tertiary center. We included 244 patients with LVT in our study. Patients who did not receive anticoagulation (n = 8) or had unknown (n = 31) outcomes were excluded. The primary outcome was a composite outcome of death, recurrent LVT and persistent LVT. We selected a total of 31 predictors collected at the point of LVT diagnosis based on clinical relevance. We compared conventional regularized logistic regression with the RF algorithm. There were 156 patients who had resolution of LVT and 88 patients who experienced the composite outcome. The RF model achieved better performance and had an AUROC of 0.700 (95% CI 0.553–0.863) on a validation dataset. The most important predictors for the composite outcome were receiving a revascularization procedure, lower visual ejection fraction (EF), higher creatinine, global wall motion abnormality, higher prothrombin time, higher body mass index, higher activated partial thromboplastin time, older age, lower lymphocyte count and higher neutrophil count. The RF model accurately identified patients with post-AMI LVT who developed the composite outcome. Further studies are needed to validate its use in clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region.
- Author
-
Tay, Edgar, Paul, Biswajit, Sharp, Jason, Wang, Dennis, Chui, Angus Shing Fung, Hazra, Prakash Kumar, Santoso, Teguh, Albers, Bert, Diener, Hans-Christoph, Lewalter, Thorsten, and Wong, Andrew
- Abstract
Purpose: To develop a consensus statement for left atrial appendage occlusion (LAAO) in Asian-Pacific patients with non-valvular atrial fibrillation (NVAF) at risk of ischemic stroke. The need for such a region-specific consensus was indicated by the relative paucity of clinical evidence for LAAO and oral anticoagulation therapy obtained in Asian-Pacific populations and the specific stroke and bleeding characteristics of this population. Methods: Consensus was developed by discussion and evaluation of available evidence and expert opinions during a 2-day meeting attended by clinical experts from the Asian-Pacific regions. Results: The consensus statement arrived at provides recommendations based on available evidence and expert opinions regarding LAAO in Asian-Pacific patients. Gaps in the evidence and other areas requiring further research were identified. Conclusion: LAAO is an alternative device-based therapy in carefully selected patients with NVAF at risk of ischemic stroke. However, evidence for LAAO is primarily obtained from Caucasian populations, and data on LAAO in Asian-Pacific patients are scarce. While the present consensus statement addresses several therapy-related aspects based on careful interpretation of available evidence and expert opinions, other areas require additional evidence derived from Asian-Pacific populations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. A percutaneous approach to create tricuspid regurgitation in swine: a model for transcatheter tricuspid valve therapy assessment.
- Author
-
Yan, Qian, Chan, Zhi Wei, Goh, Jeremy Xian Wei, Hon, Jimmy Kim Fatt, Wong, Julian Chi Leung, Kong, William Kok-Fai, and Tay, Edgar Lik Wui
- Abstract
Purpose: The purpose of this study was to develop a simple and effective percutaneous approach to create tricuspid regurgitation in swine. Methods: Eleven pigs (71.68 ± 7.70 kg, 3 male) were involved in this study. A grasping forceps was introduced into the right ventricle through a steerable sheath under fluoroscopic guidance and used to disrupt the tricuspid valve apparatus by avulsing leaflet or chordae tendineae repeatedly. Transthoracic echocardiography and right ventricular angiography were used to evaluate the degree of tricuspid regurgitation created. Results: Ten of the 11 pigs (90.91%) achieved severe tricuspid regurgitation and 1 (9.09%) obtained moderate tricuspid regurgitation immediately after the procedure. Heart rate of the pigs significantly increased immediately after tricuspid regurgitation creation compared to baseline (88.64 ± 23.24 vs. 76.00 ± 15.30 bpm, P = 0.02), but recovered to normal level at one month follow-up (77.09 ± 11.97 bpm, P = 0.85). The right atrium, tricuspid valve annulus, and right ventricle dilated obviously one month after tricuspid regurgitation creation (dimension changes: 3.01 ± 0.35 vs. 3.56 ± 0.40 cm, P = 0.02; 2.92 ± 0.36 vs. 3.37 ± 0.39 cm, P = 0.01; 3.06 ± 0.42 vs. 3.60 ± 0.47 cm, P = 0.03 respectively). Autopsy findings showed that rupture of leaflet and/or chordae tendineae finally led to the tricuspid regurgitation. Conclusions: Severe tricuspid regurgitation can be created by a simple and effective percutaneous approach with a grasping forceps in swine model and right heart dilation can be observed consistently at one-month follow-up. This model will be valuable in pre-clinical studies for developing new tricuspid valve repair or replacement technique to treat severe tricuspid regurgitation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
15. Inadequately low left ventricular mass in patients with significant aortic stenosis predicts favourable prognostic outcomes.
- Author
-
Chew, Nicholas W. S., Ngiam, Jinghao Nicholas, Tan, Benjamin Yong-Qiang, Sia, Ching-Hui, Ruan, Wen, Sim, Hui-Wen, Kong, William K. F., Tay, Edgar L. W., Yeo, Tiong-Cheng, and Poh, Kian Keong
- Abstract
In patients with significant aortic stenosis (AS), the prognostic effect of the increase in left ventricular mass (LVM) in relation to one's hemodynamic load has been described. Inappropriately high LVM has been shown to predict adverse cardiovascular events. However, little is known about the prognostic impact of inadequately low LVM (i-lowLVM) in patients with significant AS. I-lowLVM was defined as the measured LVM < 73% of the predicted LVM based on sex, stroke work and height from the reference adult population, used in previous established studies. For outcome analysis, the end-point was defined as all-cause mortality, aortic valve replacement and/or admission for congestive heart failure. Kaplan-Meier curves and multivariable Cox regression models were constructed to compare outcomes on follow-up. During the follow-up (4.5 ± 4.1 years), 132 patients (11.1%) had i-lowLVM, 868 (73.1%) had adequate-LVM, 188 (15.8%) had inappropriately high LVM. Outcome analysis only included patients with i-lowLVM and adequate-LVM (N = 1000). An adverse composite event occurred in 41.7% of the i-lowLVM group and 52.4% of the adequate-LVM group (p = 0.021). Event-free survival in patients with i-lowLVM and appropriate-LVM was 76% versus 68% at 2-year, 55% versus 46% at 4-year, 33% versus 27% at 6-year, 20% versus 17% at 8-year, and 17% versus 11% at 10-year follow-up, respectively (p < 0.001). Cox analysis revealed that i-lowLVM was independently associated with lower composite adverse outcome (HR 0.624, 95% CI 0.460-0.846, p = 0.002) after adjusting for sex, age, ejection fraction, ischemic heart disease, diabetes and transaortic valve mean gradient. In the separate Cox subanalyses, the presence of i-lowLVM remained a predictor of lower composite adverse outcome in the severe AS subgroup (HR 0.587, 95% CI 0.396-0.870, p = 0.008), and the LVH subgroup (HR 0.574, 95% CI 0.401-0.824, p = 0.003) after adjusting for confounders. I-lowLVM despite significant AS may represent a distinct group that is associated with improved survival outcomes independent of other prognostic covariates. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Help-seeking patterns and funding strategies in patients with pulmonary arterial hypertension on phosphodiesterase-5 inhibitors: an orphan disease with effective but costly treatment.
- Author
-
Yinghao Lim, Bte Maaroof, Siti Munawarah, Ting Ting Low, Kuntjoro, Ivandito, Yip, James W. L., Tay, Edgar, Lim, Yinghao, Maaroof, Siti Munawarah Bte, Low, Ting Ting, and Yip, James Wl
- Subjects
PHOSPHODIESTERASE-5 inhibitors ,PULMONARY hypertension ,HELP-seeking behavior ,FINANCIAL stress ,MEDICAL personnel ,ORPHANS ,SYMPTOMS ,ESTERASES ,PHOSPHODIESTERASE inhibitors - Abstract
Introduction: Pulmonary arterial hypertension (PAH) is associated with high medical and pharmaceutical costs. Phosphodiesterase type 5 (PDE5) inhibitors have been found to be beneficial but costly. They are not subsidised in Singapore except via the Medication Assistance Fund (MAF) Plus scheme. In this study, we described the help-seeking behaviour of patients and funding strategies for Singaporean patients on PDE5 inhibitors in our registry.Methods: We consecutively recruited all patients with PAH who presented to our pulmonary hypertension specialty centre between 1 January 2003 and 29 December 2016. Singaporean patients on PDE5 inhibitors were included. Data recorded and analysed for this study included baseline demographics, whether the patients received MAF Plus funding, percentage of funding, and any additional source of subsidies.Results: 114 (77.0%) of 148 patients in the registry were Singapore citizens on PDE5 inhibitors. 75 (65.8%) of these 114 patients had been seen by a medical social worker, of whom 16 were on MAF Plus funding. 14 of the remaining 59 patients were subsidised by MediFund, whereas the remainder were self-paying. 30 (26.3%) patients in total were on some form of subsidy, and 28 (24.6%) patients were on combination therapy. Of this group, nine were receiving MAF Plus subsidies.Conclusion: Fewer than expected patients were found to be receiving drug subsidies for PAH. This was partly due to insufficient referrals and lack of requests for financial assistance. Patients on combination therapy had greater financial challenges. This study should spur us on to study funding gaps further and address them. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
17. Transcatheter aortic valve implantation during the COVID-19 pandemic: Clinical expert opinion and consensus statement for Asia.
- Author
-
Tay, Edgar L., Hayashida, Kentaro, Chen, Mao, Yin, Wei‐Hsien, Park, Duk‐Woo, Seth, Ashok, Kao, Hsien‐Li, Lin, Mao‐Shin, Ho, Kay‐Woon, Buddhari, Wacin, Chandavimol, Mann, Posas, Fabio‐Enriques, Nguyen, Quang N., Kong, William, Rosli, M. A., Hon, Jimmy, Firman, Doni, Lee, Michael, Yin, Wei-Hsien, and Park, Duk-Woo
- Subjects
COVID-19 pandemic ,HEART valve prosthesis implantation ,AORTIC stenosis ,COVID-19 ,TREND setters - Abstract
Objectives: The impact of the COVID-19 pandemic on the treatment of patient with aortic valve stenosis is unknown and there is uncertainty on the optimal strategies in managing these patients.Methods: This study is supported and endorsed by the Asia Pacific Society of Interventional Cardiology. Due to the inability to have face to face discussions during the pandemic, an online survey was performed by inviting key opinion leaders (cardiac surgeon/interventional cardiologist/echocardiologist) in the field of transcatheter aortic valve implantation (TAVI) in Asia to participate. The answers to a series of questions pertaining to the impact of COVID-19 on TAVI were collected and analyzed. These led subsequently to an expert consensus recommendation on the conduct of TAVI during the pandemic.Results: The COVID-19 pandemic had resulted in a 25% (10-80) reduction of case volume and 53% of operators required triaging to manage their patients with severe aortic stenosis. The two most important parameters used to triage were symptoms and valve area. Periprocedural changes included the introduction of teleconsultation, preprocedure COVID-19 testing, optimization of protests, and catheterization laboratory set up. In addition, length of stay was reduced from a mean of 4.4 to 4 days.Conclusion: The COVID-19 pandemic has impacted on the delivery of TAVI services to patients in Asia. This expert recommendation on best practices may be a useful guide to help TAVI teams during this period until a COVID-19 vaccine becomes widely available. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
18. Echocardiographic discrepancies in severity grading of aortic valve stenosis with left ventricular outflow tract (LVOT) cut-off values in an Asian population.
- Author
-
Chew, Nicholas W. S., Ngiam, Jinghao Nicholas, Tan, Benjamin Yong-Qiang, Sia, Ching-Hui, Sim, Hui Wen, Kuntjoro, Ivandito, Kong, William K. F., Tay, Edgar L. W., Yeo, Tiong-Cheng, and Poh, Kian Keong
- Abstract
Inconsistencies in grading of aortic stenosis (AS) severity have been reported. However, it remains to be studied in an Asian population. We investigated consistency of grading AS severity at various left ventricular outflow tract diameter (LVOTd) categories, and postulated alternative cut-offs for more consistent grading of AS severity. Consecutive Asian patients (n = 350) with index echocardiographic diagnosis of severe AS were divided them into three groups based on LVOTd: 'small' (< 20 mm), 'average' (20-22 mm) and 'large' (> 22 mm). In each group, the consistency of flow-dependent (transaortic mean pressure gradient (MG)) and flow-independent parameters (AVA) were used for classification of AS severity. Of 350 patients, 51.7% had small LVOTd, while 30.8% and 17.5% had average and large LVOTd respectively. Consistent grading by LVOTd based on AVA and MG, was seen in 33.7% of patients with small, 47.6% with average, 57.7% with large LVOTd. When an AVA cut-off of 0.9 cm2 was used, consistent grading improved to 38.0% in small, 56.5% in average and 70.0% in large LVOTd. At an AVA cut-off of 0.8 cm2, there was further incremental improvement in the small LVOTd group to 54.1% (p < 0.05). In conclusion, current severe AS guidelines are most inconsistent with those in the small LVOTd group. With majority of the study's Asian population having small LVOTd, this raises concerns that current AS guidelines may overestimate the severity of AS in the Asian cohort. Improved consistency in echocardiographic grading may be attained with a lower AVA cut-off in this Asian cohort. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Clinical and echocardiographic features of paradoxical low-flow and normal-flow severe aortic stenosis patients with concomitant mitral regurgitation.
- Author
-
Ngiam, Jinghao Nicholas, Chew, Nicholas, Teng, Rebecca, Kochav, Jonathan D., Kochav, Stephanie M., Tan, Benjamin Yong-Qiang, Sim, Hui Wen, Sia, Ching-Hui, Kong, William K. F., Tay, Edgar Lik Wui, Yeo, Tiong-Cheng, and Poh, Kian-Keong
- Abstract
Mitral regurgitation (MR) coexists in a significant proportion of patients with severe aortic stenosis (AS), and portends inferior therapeutic outcomes. In severe AS, MR is thought to contribute to a low-flow state by decreasing forward stroke volume. We investigated concomitant MR on the clinical and echocardiographic features of patients with "paradoxical" low-flow (PLF) and normal-flow (NF) severe AS. Clinical and echocardiographic profiles of 886 consecutive patients with index echocardiographic diagnosis of severe AS (AVA < 1.0 cm2) were analysed retrospectively. All patients had preserved ejection fraction (LVEF ≥ 50%, n = 645), and were divided into PLF (stroke volume index, SVI < 35 mL/m2) and NF AS. They were then further subdivided based on the presence or absence of moderate-or-severe MR (msMR). A higher prevalence of concomitant msMR was observed in patients with PLF AS (14.9%; n = 33/221) compared to those with NF AS (8.0%; n = 34/424). Concomitant msMR was associated with echocardiographic features of increased diastolic dysfunction in both PLF AS and NF AS patients, as evidenced by increased LA diameter (PLF AS 52.9 ± 12.5 to 43.9 ± 8.9 mm; NF AS 29.6 ± 10.8 to 42.4 ± 8.8 mm; p < 0.001) and increased transmitral E/A ratio (PLF AS 1.26 ± 0.56 to 0.92 ± 0.43; NF AS 1.19 ± 0.63 to 0.94 ± 0.45; p = 0.004). Amongst patients with NF AS, msMR was additionally associated with increased E:e' ratio (25.5 ± 15.1 vs 19.3 ± 10.8; p = 0.025). Concomitant MR was more common in PLF AS compared to NF. Although possibly related to the MR, patients severe AS and MR appeared to have more severe diastolic dysfunction. Further studies are warranted to evaluate prognosis and guide management. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. Ventricular vortex loss analysis due to various tricuspid valve repair techniques: an ex vivo study.
- Author
-
Yen Ngoc Nguyen, Lik Wui Tay, Edgar, Kabinejadian, Foad, Chi Wei Ong, Ismail, Munirah, and Hwa Liang Leo
- Abstract
The deteriorating nature of severe functional tricuspid regurgitation (FTR) has led to the heightened interest in this pathology. However, therapies are heterogeneous and an ideal technique is uncertain. The hemodynamic impact on the cardiac chamber following therapeutic repairs has not been well studied, while its analysis could be used to predict the treatment success. In this study, the hemodynamics of the right ventricle (RV) after 1) clover edge-to-edge tricuspid repair, and 2) double orifice tricuspid repair was evaluated in three right heart models using an ex vivo pulsatile platform emulating severe FTR with the aid of stereoscopic particle image velocimetry. Although all repairs substantially reduced tricuspid regurgitant area, they resulted in a more than 50% reduction in diastolic tricuspid valve (TV) opening area. Splitting the TV orifice into multiple smaller orifices by both repairs eliminated the ring-shaped vortical structure inside the RV observed in FTR cases. Postrepair RV domain was mostly occupied with irregular vortical features and isolated vortex residuals. Moreover, vortical features varied among repair samples, indicating enhanced sensitivity of RV flow to postrepair TV morphology. Compared with clover repair, double orifice subjected the RV to enhanced swirling motions and exposed more regions to vortical motions, potentially indicating better rinsing and lower risk of mural thrombus formation. Double orifice repair increased the levels of RV mean kinetic energy and viscous energy loss than those observed in clover repair, although the impact of these on the cardiac efficiency remains unclear. These preliminary insights could be used to improve future treatment design and planning. NEW & NOTEWORTHY While clover and double orifice tricuspid repairs markedly improved leaflet coaptation, they substantially reduced diastolic tricuspid opening area. Postrepair right ventricle (RV) exhibited specific hemodynamic traits, including the loss of ring-shaped vortical structure and the enhanced sensitivity of RV flow to postrepair tricuspid valve morphology. Compared with clover technique, double orifice repair led to higher swirling motions in the RV domain, which could indicate lower risk of mural thrombus formation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
21. Mid-term study of transcatheter aortic valve implantation in an Asian population with severe aortic stenosis: two-year Valve Academic Research Consortium-2 outcomes.
- Author
-
Chew, Nicholas, Kim Fatt, Jimmy, Wei Luen James Yip, Siew Pang Chan, Kian-Keong Poh, Kok-Fai Kong, William, Leok Kheng Teoh, Kristine, Tiong Cheng Yeo, Huay Cheem Tan, Lik Wui Tay, Edgar, Hon, Jimmy Kim Fatt, Yip, Wei Luen James, Chan, Siew Pang, Poh, Kian-Keong, Kong, William Kok-Fai, Teoh, Kristine Leok Kheng, Yeo, Tiong Cheng, Tan, Huay Cheem, and Tay, Edgar Lik Wui
- Subjects
AORTIC valve transplantation ,AORTIC stenosis ,PATIENT readmissions ,SYMPTOMS ,ASIANS ,PATIENTS - Abstract
Introduction: Transcatheter aortic valve implantation (TAVI) is an effective treatment for high-risk or inoperative patients with severe aortic stenosis. Given the unique characteristics of Asian populations, questions regarding mid-term outcomes in Asians undergoing TAVI have yet to be addressed. We evaluated the two-year clinical outcomes of TAVI in an Asian population using Valve Academic Research Consortium-2 definitions.Methods: This prospective study recruited 59 patients from a major academic medical centre in Singapore. The main outcomes were two-year survival rates, peri-procedural complications, symptom improvement, valvular function and assessment of learning curve.Results: Mean age was 76.8 years (61.0% male), mean body surface area 1.6 m2 and mean logistic EuroSCORE 18.7%. Survival was 93.2%, 86.0% and 79.1% at 30 days, one year and two years, respectively. At 30 days post TAVI, the rate of stroke was 1.7%, life-threatening bleeding 5.1%, acute kidney injury 25.0%, major vascular complication 5.1%, and new permanent pacemaker implantation 6.8%. 29.3% of TAVI patients were rehospitalised (47.1% cardiovascular-related) within one year. These composite outcomes were measured: device success (93.2%); early safety (79.7%); clinical efficacy (66.1%); and time-related valve safety (84.7%). Univariate analysis found these predictors of two-year all-cause mortality: logistic EuroSCORE (hazard ratio [HR] 1.07; p < 0.001); baseline estimated glomerular filtration rate (HR 0.97; p = 0.048); and acute kidney injury (HR 5.33; p = 0.022). Multivariate analysis identified non-transfemoral TAVI as a predictor of cardiovascular-related two-year mortality (HR 14.64; p = 0.008).Conclusion: Despite the unique clinical differences in Asian populations, this registry demonstrated favourable mid-term clinical and safety outcomes in Asians undergoing TAVI. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
22. Characterisation of acute ischemic stroke in patients with left ventricular thrombi after myocardial infarction.
- Author
-
Leow, Aloysius Sheng-Ting, Sia, Ching-Hui, Tan, Benjamin Yong-Qiang, Kaur, Rajinderdeep, Yeo, Tiong-Cheng, Chan, Mark Yan-Yee, Tay, Edgar Lik-Wui, Seet, Raymond Chee-Seong, Loh, Joshua Ping-Yun, and Yeo, Leonard Leong-Litt
- Abstract
Acute ischemic stroke (AIS) is a feared complication in post-acute myocardial infarction (AMI) patients who develop left ventricular (LV) thrombus. There is limited data available on the incidence of stroke in this population, and characterisation of stroke subtypes has not been previously reported. Our study aims to evaluate the incidence of AIS in post-AMI patients with LV thrombus and to characterise the pattern of stroke subtypes. We screened 5829 patients with echocardiogram reports containing the "thrombus" keyword from August 2006 to September 2017. AIS that occurred after LV thrombosis was captured and relevant clinical data was collected. We identified 289 post-AMI patients with acute LV thrombus formation. Mean age was 59.3 ± 13.4 years. AIS occurred in 34 patients (11.8%), median duration of 20.5 days (IQR = 5.5–671.8) after LV thrombosis. Despite initial thrombus resolution, nine (5.2%) encountered AIS subsequently. Cardioembolic stroke subtype was identified in 76.5% of AIS, whilst 14.7% was small vessel disease and 8.8% was of large artery atherosclerosis subtype. Presence of thrombus protrusion (HR 3.04, 95% CI 1.25–7.41, p = 0.01), failure of initial thrombus resolution (HR 3.03, 95% CI 1.23–7.45, p = 0.02) and thrombus recurrence (HR 4.20, 95% CI 1.46–12.11, p < 0.01) were significant independent predictors for stroke. Incidence of AIS in this Asian population of post-AMI patients with LV thrombus was 11.8%. Duration of anticoagulation may need to be individualised for patients with higher risk for stroke occurrence after LV thrombosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
23. Pulmonary arterial hypertension in a multi‐ethnic Asian population: Characteristics, survival and mortality predictors from a 14‐year follow‐up study.
- Author
-
Lim, Yinghao, Low, Ting‐Ting, Kuntjoro, Ivandito, Tay, Edgar Lik‐Wui, Yip, James Wei‐Luen, Chan, Siew‐Pang, Teo, Ting Wei, Jang, Jin‐Hao Justin, and Yip, Nicole
- Subjects
PULMONARY hypertension ,PROGRESSION-free survival ,MEDICAL care ,CHI-squared test ,ETIOLOGY of diseases - Abstract
Background and objective: Pulmonary arterial hypertension (PAH) is a rare and fatal disease. Data from Asia are lacking compared with the West. We aim to describe disease characteristics in an ethnically diverse South‐East Asian population and assess predictors for survival. Methods: We consecutively enrolled patients with PAH referred to our pulmonary hypertension specialty centre from January 2003 to December 2016. Baseline characteristics and survival were analysed. Based on a forward predictor selection procedure, a multi‐level structural equation model was applied to identify predictors associated with mortality. Results: Out of 148 patients enrolled, 77% were females and mean age was 50.8 ± 15.9 years. Racial distribution was consistent with our population census. The most common aetiologies were congenital heart disease‐associated PAH (35.8%), idiopathic PAH (29.7%) and then connective tissue disease‐associated PAH (24.3%). Most patients presented in World Health Organization (WHO) Functional Class (FC) II (48.6%), followed by FC III (28.8%). Majority of patients (54.1%) were on phosphodiesterase type 5 (PDE5) inhibitor monotherapy. Survival rates were 85.8% at the end of the first year, 70.9% at 3 years, 66.9% at 5 years, 61.5% at 7 years and 55.4% at 10 years. The Registry to Evaluate Early And Long‐term PAH Disease Management (REVEAL) score (RS) was found to be the best predictor of mortality. A score > 6 was identified as a cut‐off. Other predictors include mean right atrial pressure, heart rate, aetiology, age and N‐terminal pro‐brain natriuretic peptide. Conclusion: In this first registry study from a South‐East Asian population, our survival rates are comparable with other national registries. The RS is validated in our population to be a good predictor of mortality. This is the first detailed pulmonary arterial hypertension (PAH) registry study from a multi‐ethic Asian cohort with a long 14‐year follow‐up. Data are sorely lacking in the East compared with the West. We were able to apply and validate risk predictors including the REVEAL (Registry to Evaluate Early And Long‐term PAH Disease Management) score. See relatedEditorial [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Incidence and predictors of target lesion failure in a multiethnic Asian population receiving the SYNERGY coronary stent: A prospective all‐comers registry.
- Author
-
Ananthakrishna, Rajiv, Kristanto, William, Liu, Li, Chan, Siew‐Pang, Loh, Poay Huan, Tay, Edgar L., Chan, Koo Hui, Chan, Mark Y., Lee, Chi‐Hang, Low, Adrian F., Tan, Huay Cheem, and Loh, Joshua P.
- Published
- 2018
- Full Text
- View/download PDF
25. Correction to: First use of large-bore suction thrombectomy for acute pulmonary embolism in Asia-Pacific: feasibility and short-term clinical outcomes.
- Author
-
Kojodjojo, Pipin, Ong, Heng Ann, Huan Loh, Poay, Tay, Edgar, Chang, Peter, Kuntjoro, Ivandito, Low, Ting-Ting, and Lim, Yinghao
- Published
- 2023
- Full Text
- View/download PDF
26. Inter-ethnic differences in valve morphology, valvular dysfunction, and aortopathy between Asian and European patients with bicuspid aortic valve.
- Author
-
Kong, William K F, Regeer, Madelien V, Poh, Kian K, Yip, James W, Rosendael, Philippe J van, Yeo, Tiong C, Tay, Edgar, Kamperidis, Vasileios, Velde, Enno T van der, and Mertens, Bart
- Abstract
Background Transcatheter aortic valve replacement (TAVR) has been shown safe and feasible in patients with bicuspid aortic valve (BAV) morphology. Evaluation of inter-ethnic differences in valve morphology and function and aortic root dimensions in patients with BAV is important for the worldwide spread of this therapy in this subgroup of patients. Comparisons between large European and Asian cohorts of patients with BAV have not been performed, and potential differences between populations may have important implications for TAVR. Aim The present study evaluated the differences in valve morphology and function and aortic root dimensions between two large cohorts of European and Asian patients with BAV. Methods and results Aortic valve morphology was defined on transthoracic echocardiography according to the number of commissures and raphe: type 0 = no raphe and two commissures, type 1 = one raphe and two commissures, type 2 = two raphes and one commissure. Aortic stenosis and regurgitation were graded according to current recommendations. For this study, aortic root dimensions were manually measured on transthoracic echocardiograms at the level of the aortic annulus, sinus of Valsalva (SOV), sinotubular junction (STJ), and ascending aorta (AA). Of 1427 patients with BAV (45.2± 18.1 years, 71.9% men), 794 (55.6%) were Europeans and 633 (44.4%) were Asians. The groups were comparable in age and proportion of male sex. Asians had higher prevalence of type 1 BAV with raphe between right and non-coronary cusps than Europeans (19.7% vs. 13.6%, respectively; P < 0.001), whereas the Europeans had higher prevalence of type 0 BAV (two commissures, no raphe) than Asians (14.5% vs. 6.8%, respectively; P < 0.001). The prevalence of moderate and severe aortic regurgitation was higher in Europeans than Asians (44.2% vs. 26.8%, respectively; P < 0.001) whereas there were no differences in BAV with normal function or aortic stenosis. After adjusting for demographics, comorbidities and valve function, the dimensions of the aortic annulus [mean difference 1.17 mm/m
2 , 95% confidence interval (CI) 0.96-1.39], SOV (mean difference 1.86 mm/m2 , 95% CI 1.47-2.24), STJ (mean difference 0.52 mm/m2 , 95% CI 0.14-0.90) and AA (mean difference 1.05 mm/m2 , 95% CI 0.57-1.52) were significantly larger among Asians compared with Europeans. Conclusions This large multicentre registry reports for the first time that Asians with BAV showed more frequently type 1 BAV (with fusion between right and non-coronary cusp) and have larger aortic dimensions than Europeans. These findings have important implications for prosthesis type and size selection for TAVR. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
27. Design and Development of Novel Transcatheter Bicaval Valves in the Interventional Treatment of Tricuspid Regurgitation.
- Author
-
Ismail, Munirah, Kabinejadian, Foad, Nguyen, Yen Ngoc, Tay, Edgar Lik Wui, and Leo, Hwa Liang
- Subjects
HEART valve diseases ,TRICUSPID valve ,HEART valves ,SURGICAL stents ,SHEARING force ,THERAPEUTICS - Abstract
Abstract: The concept of heterotopic implantation of transcatheter tricuspid valve is new and has shown promising results thus far. While the Reynolds shear stress values measured in the vicinity of this valve are relatively low, the values at some time points are higher than the threshold of platelet activation. Hence, in this study, we aim to reduce these values with an innovative stent design. It was shown that the Reynolds shear stress values measured were lower than those of valves made of generic stent design and the maximum Reynolds shear stress values in the vicinity of the valves was very low (∼10 dynes/cm
2 ). The results also depicted the interesting flow phenomenon of this non‐physiological treatment approach. Thus, this study has shown that bicaval valves could potentially be considered as a minimally invasive option to treat tricuspid regurgitation and valve design improvements could reduce the flow disturbances that were observed. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
28. Experimental Study of Right Ventricular Hemodynamics After Tricuspid Valve Replacement Therapies to Treat Tricuspid Regurgitation.
- Author
-
Nguyen, Yen, Ismail, Munirah, Kabinejadian, Foad, Ong, Chi, Tay, Edgar, and Leo, Hwa
- Abstract
The increased understanding of right heart diseases has led to more aggressive interventions to manage functional tricuspid regurgitation (FTR). In some cases of FTR, prosthetic valve replacement is typically considered when concomitant organic components or significant geometrical distortions are involved in the pathology of the tricuspid valve. However, little is known of the performance of current devices in the right heart circulation. In this study, a novel in vitro mock circulatory system that incorporated a realistic tricuspid valve apparatus in a patient-specific silicon right ventricle (RV) was designed and fabricated. The system was calibrated to emulate severe FTR, enabling the investigation of RV hemodynamics in pre- and post-implantation of tri-leaflet tissue implant and bi-leaflet mechanical implant. 2D particle imaging velocimetry was performed to visualize flow and quantify relevant hemodynamic parameters. While our results showed all prosthetic implants improved cardiac output, these implants also subjected the RV to increased turbulence level. Our study also revealed that the implants did not create the optimal behavior of fluid transfer in the RV as we expected. Among the implants tested, tissue implant created the most dominant vortices, which persisted throughout diastole; its observed strong negative vortex could lead to increase energy expenditure due to undesired fluid direction. In contrast, both native valve and mechanical implant had both weaker vortex formation as well as more significant vortex dissipation. Interestingly, the vortex dissipation of native valve was associated with streamlined flow pattern that tended towards the pulmonary outlet, while the mechanical implant generated more regions of flow stagnation within the RV. These findings heighten the imperative to improve designs of current heart valves to be used in the right circulation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
29. Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?
- Author
-
Yeo, Leonard, Andersson, Tommy, Yee, Kong, Tan, Benjamin, Paliwal, Prakash, Gopinathan, Anil, Nadarajah, Mahendran, Ting, Eric, Teoh, Hock, Cherian, Robin, Lundström, Erik, Tay, Edgar, and Sharma, Vijay
- Abstract
A cardiocerebral ischemic attack (CCI) or a concurrent acute ischemic stroke (AIS) and myocardial infarction (AMI) is a severe event with no clear recommendations for ideal management because of the rarity of the scenario. The narrow time window for treatment and complexity of the treatment decision puts immense pressure on the treating physician. We evaluated this challenging situation at our tertiary center. Using our prospective stroke database out of a total of 555 patients with acute ischemic stroke between 2009 and 2014, we identified five consecutive cases with CCI (incidence 0.009%). Demography, risk factor characteristics, vascular occlusions and treatment approach were recorded. Good functional outcome was defined by the modified Rankin scale (mRS) score of 0-2 points. Out of five patients, AIS was treated with endovascular treatment in three cases, while two were treated with intravenous thrombolysis only. One out of three patients had embolectomy of the brain performed prior to the coronary intervention, while the other two patients underwent coronary intervention first. One patient developed sudden cardiac arrest on day-2 and passed away. CCI is an uncommon and devastating clinical scenario, further research is needed for the ideal management strategy that provides the best outcomes. However, the rarity of the disease does not lend itself to the conduct of a trial easily. We have proposed a considered treatment algorithm based on the current literature and our experience. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
30. Nongated Cardiac Computed Tomographic Angiograms for Detection of Embolic Sources in Acute Ischemic Stroke.
- Author
-
Yeo, Leonard L. L., Holmin, Staffan, Andersson, Tommy, Lundström, Erik, Gopinathan, Anil, Er Luen Lim, Leong, Benjamin S. H., Win Sen Kuan, Ting, Eric, Tan, Benjamin Y. Q., Eide, Sterling Ellis, Tay, Edgar L. K., Lim, Er Luen, and Kuan, Win Sen
- Published
- 2017
- Full Text
- View/download PDF
31. An Experimental and Computational Study on the Effect of Caval Valved Stent Oversizing.
- Author
-
Ismail, Munirah, Kumar, Gideon, Kabinejadian, Foad, Nguyen, Yen, Cui, Fangsen, Tay, Edgar, and Leo, Hwa
- Abstract
Heterotopic implantation of transcatheter tricuspid valve is a new treatment option for tricuspid regurgitation. Transcatheter tricuspid valves are implanted onto the cavoatrial junction in order to avoid the challenging task of anchoring the valve onto the complex tricuspid valve annulus. However, little is known about optimum extent of oversizing of the valved stent in a vena cava. In this study, we implanted valves of the same diameter onto the larger sized inferior vena cava (IVC) and a smaller sized superior vena cava (SVC). The valve in the IVC was oversized by 10.7% while the valve in the SVC was oversized by 21.6%. Finite element analysis was performed (i) to assess the strain on the nitinol stent during manufacturing and deployment; (ii) the stents were deployed in a patient-specific vena cava model and the intramural stress of the vena cava was calculated computationally. These valves were fabricated and placed in a silicone model of a patient-specific right atrium which was part of a mock circulatory system that emulated the patho-physiological flow rate and pressure of a patient with tricuspid regurgitation. Flow measurements were conducted by particle image velocimetry (PIV). It was found that the maximum crimping strain on the nitinol stent was 6.85% which was lower than the critical threshold of 10%. The maximum stress on the vena cava was located at the spot where the hooks met the wall. The maximum stress on the IVC was 0.5098 MPa while the maximum stress on the SVC was 0.7 MPa. The maximum Reynolds shear stress (mRSS) in the vena cava was found to be higher in the IVC than SVC with the highest mRSS being 1741 dynes/cm found in the region of high flow during the peak flow phase. The overtly oversized valve in the SVC did not cause flow disturbances and exhibited mostly laminar flows. The mRSS at the downstream of the vena cava valve and the middle of the atrium remained at low magnitudes. However, velocity fluctuations were high in the IVC in all the time points measured. In conclusion, oversizing the valve may assist anchorage; yet, careful consideration should be taken in choosing the extent of oversizing as it may lead to adverse effects. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
32. The MitraClip Asia-Pacific registry: Differences in outcomes between functional and degenerative mitral regurgitation.
- Author
-
Tay, Edgar, Muda, Nasir, Yap, Jonathan, Muller, David W.M., Santoso, Teguh, Walters, Darren L., Liu, Xianbao, Yamen, Eric, Jansz, Paul, Yip, James, Zambahari, Robaayah, Passage, Jurgen, Ding, Zee Pin, Wang, Jian'an, Scalia, Gregory, Soesanto, Amiliana M., and Yeo, Khung Keong
- Published
- 2016
- Full Text
- View/download PDF
33. How temporal evolution of intracranial collaterals in acute stroke affects clinical outcomes.
- Author
-
Yeo, Leonard L L, Paliwal, Prakash, Low, Adrian F, Tay, Edgar L W, Gopinathan, Anil, Nadarajah, Mahendran, Ting, Eric, Venketasubramanian, Narayanaswamy, Seet, Raymond C S, Ahmad, Aftab, Chan, Bernard P L, Teoh, Hock L, Soon, Derek, Rathakrishnan, Rahul, and Sharma, Vijay K
- Published
- 2016
- Full Text
- View/download PDF
34. How temporal evolution of intracranial collaterals in acute stroke affects clinical outcomes.
- Author
-
Yeo, Leonard L. L., Paliwal, Prakash, Low, Adrian F., Tay, Edgar L. W., Gopinathan, Anil, Nadarajah, Mahendran, Ting, Eric, Venketasubramanian, Narayanaswamy, Seet, Raymond C. S., Ahmad, Aftab, Chan, Bernard P. L., Teoh, Hock L., Soon, Derek, Rathakrishnan, Rahul, and Sharma, Vijay K.
- Published
- 2016
- Full Text
- View/download PDF
35. Management of severe aortic stenosis: the Singapore and Asian perspective.
- Author
-
Edgar Lik Wui Tay, Ngiam, Jinghao Nicholas, Kong, William K. F., Kian-Keong Poh, Tay, Edgar Lik Wui, Kong, William Kf, and Poh, Kian-Keong
- Subjects
AORTIC stenosis treatment ,AORTIC valve ,AORTIC stenosis ,ASIANS ,CARDIOLOGY ,CARDIOVASCULAR surgery ,RELATIVE medical risk ,SEVERITY of illness index - Abstract
An editorial is presented which discusses the management of aortic valve stenosis (AS). Mentioned is the decision of the American College of Cardiology on updating guidelines on the management of valvular heart diseases. Tackled is the statistics conducted by the World Health Organization on the treatment of AS.
- Published
- 2018
- Full Text
- View/download PDF
36. Managing the Eisenmenger syndrome: a call to arms.
- Author
-
Tay, Edgar L. W.
- Subjects
EISENMENGER syndrome ,PULMONARY hypertension ,PALLIATIVE treatment ,LUNG transplantation ,HEART transplantation ,HEART abnormalities ,VASODILATORS - Published
- 2018
- Full Text
- View/download PDF
37. In Vitro Investigation of the Hemodynamics of Transcatheter Heterotopic Valves Implantation in the Cavo-Atrial Junction.
- Author
-
Ismail, Munirah, Kabinejadian, Foad, Nguyen, Yen Ngoc, Tay, Edgar, Kim, Sangho, and Leo, Hwa Liang
- Subjects
HEMODYNAMICS ,HYDRODYNAMICS ,BLOOD circulation ,BIOLOGICAL fluid dynamics ,FLUID dynamics - Abstract
Severe tricuspid regurgitation ( TR) is life-threatening but is often undertreated. Many patients with severe TR are denied heart valve replacement surgery because their old age or comorbidities predispose them to a higher risk of surgical complications associated with open-heart surgery. With the advent of transcatheter technology, it is now possible to deliver the valve to the desired location without the need for open-heart surgery. However, presently, there is no commercially available transcatheter tricuspid valve. This may be due to the complex tricuspid valve anatomy, which lacks an anchorage zone for the percutaneous valves. In view of this drawback, we have recently developed and tested two percutaneous caval heart valves that are designed to deploy at the vena cava and atrium junction. The hemodynamic characteristics of these valves are tested in a mock circulatory system with patient-specific silicone atrium and vena cava, which emulates the physiological pressure and flow conditions at the right side of the human heart. Particle imaging velocimetry results showed that flow velocity and the associated Reynolds shear stress ( RSS) and the turbulent kinetic energy ( TKE) downstream of the valves increased after the implantation of the valves. A maximum flow velocity of 0.94 m/s was observed at the region downstream of the percutaneous valve at the superior vena cava ( SVC). Maximum RSS value of 2076.1 dynes/cm
2 was observed downstream of the valve at the inferior vena cava during the deceleration phase while maximum TKE measured was 572.6 J/m3 at the upstream of the valve in the SVC during the peak flow phase. While these values appear high, they are significantly lower than those reported in prosthetic mitral and aortic valves. Hence, caval stented valves can be potentially considered as a minimally invasive option to treat TR. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
38. Effectiveness of early cardiology undergraduate learning using simulation on retention, application of learning and level of confidence during clinical clerkships.
- Author
-
Weiqin Lin, Lee, Glenn K., Loh, Joshua P., Tay, Edgar L., Sia, Winnie, Tang-Ching Lau, Shing-Chuan Hooi, and Kian-Keong Poh
- Subjects
CARDIOLOGY ,MEDICAL students ,MEDICAL education ,CLINICAL clerkship ,UNDERGRADUATES ,SIMULATION methods in higher education ,OBSERVED confidence levels (Statistics) ,EDUCATION - Abstract
INTRODUCTION This study aimed to assess the effectiveness of the use of a cardiopulmonary patient simulator in the teaching of second-year medical students. Effectiveness was measured in terms of the extent of knowledge retention and students' ability to apply the skills learned in subsequent real-life patient contact. METHODS In this study, ten third-year medical students who had previously undergone simulator training as part of their second-year curriculum underwent an objective structured clinical examination (OSCE) and a multiple-choice question (MCQ) test to assess their ability to apply the knowledge gained during the simulator training when dealing with real patients. The performance of this group of students was compared with that of a group of ten fourth-year medical students who did not undergo simulation training. RESULTS Although the third-year medical students performed well in the OSCE, they were outperformed by the group of fourth-year medical students, who had an extra year of clinical exposure. The MCQ scores of the two groups of students were similar. Post-simulation training survey revealed that students were generally in favour of incorporating cardiopulmonary simulator training in the preclinical curriculum. CONCLUSION Cardiopulmonary simulator training is a useful tool for the education of preclinical medical students. It aids the translation of preclinical knowledge into real-life clinical skills. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
39. Transcatheter Aortic Valve Implantation Emerging as Good Alternative to Surgery for Aortic Stenosis-Present Status.
- Author
-
Tay, Edgar
- Published
- 2015
- Full Text
- View/download PDF
40. MitraClip: Acute Thrombus Formation During Guide Insertion.
- Author
-
Tay, Edgar L. W., Poh, Kian Keong, Wong, Raymond, and Yip, James Wei Luen
- Published
- 2013
- Full Text
- View/download PDF
41. Redo MitraClip mitral valve repair after a late single leaflet detachment.
- Author
-
Tay, Edgar L.W., Lim, D. Scott, and Yip, James
- Published
- 2014
- Full Text
- View/download PDF
42. Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.
- Author
-
Poh, Kian-Keong, Xu, Xin, Chan, Mark, Lee, Chi-Hang, Tay, Edgar, Low, Adrian, Chan, Koo, Sia, Winnie, Tang, Liang-Qiu, Tan, Huay, Lui, Charles, Nguyen, Vincent, Fujise, Kenichi, and Huang, Ming-He
- Subjects
ADRENERGIC beta agonists ,SYMPATHOLYTIC agents ,MILRINONE ,ANALYSIS of variance ,COMBINATION drug therapy ,CHI-squared test ,HEMODYNAMICS ,INTRAOPERATIVE care ,MYOCARDIAL infarction ,MYOCARDIAL reperfusion complications ,MYOCARDIAL revascularization ,HEALTH outcome assessment ,REGRESSION analysis ,RESEARCH funding ,TRANSLUMINAL angioplasty ,PILOT projects ,TREATMENT effectiveness ,REPEATED measures design ,ACUTE diseases ,DATA analysis software ,DESCRIPTIVE statistics ,THERAPEUTICS - Abstract
Purpose: Ischemia/reperfusion injury remains an untreated clinical problem in patients with acute myocardial infarction (AMI) despite significant advances in emergent revascularization through percutaneous coronary intervention (PCI). Pharmacological intervention for infarct size reduction is unavailable. We have identified that the medications milrinone and esmolol, when administered together at the beginning of the reperfusion, significantly decrease infarct size via reducing reperfusion injury in an experimental model. The present study tested the safety of combination therapy of milrinone and esmolol (M + E) in patients with AMI. Methods: Sixteen subjects with AMI requiring PCI were consecutively recruited. M + E was intravenously infused simultaneously for 10 min started at 5 min before anticipated angioplasty balloon inflation. Another 16 consecutively recruited AMI patients requiring PCI served as a placebo arm treated per routine clinical protocol. Blood pressure (BP) and heart rate (HR) were monitored continuously during PCI. Results: M + E combination therapy resulted in a trend of non-significant reduction in BP compared with a control group. There was a modest but significant increase in HR at the later phase of M + E infusion compared with a control group. No significant cardiac arrhythmia was induced during M + E infusion. Conclusions: The combination therapy with M + E produces a minimal change in hemodynamics and appears safe as an adjunctive therapy to PCI in AMI patients. Further studies are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
43. Transcatheter aortic valve implantation: implications for Asian patients.
- Author
-
Tay, Edgar LW, Yip, James Wei-Luen, Teoh, Kristine LK, Ang, Sophia, Poh, Kian Keong, Teo, Lynette LS, Yeo, Tiong Cheng, Lee, Chuen Neng, Tan, Huay Cheem, and Hon, Jimmy KF
- Published
- 2013
- Full Text
- View/download PDF
44. Demographics of severe valvular aortic stenosis in Singapore.
- Author
-
Tay EL, Lew PS, Poh KK, Saclolo R, Chia BL, Yeo TC, Tan HC, Yip JW, Tay, Edgar L W, Lew, Pei Shi, Poh, Kian Keong, Saclolo, Rafael, Chia, Boon-Lock, Yeo, Tiong Cheng, Tan, Huay Cheem, and Yip, James W L
- Abstract
Introduction: The treatment of aortic valve stenosis (AS) is seeing renewed interest mainly due to the availability of transcatheter therapies. However, the number of epidemiological studies of this disease in Singapore is limited. We aimed to describe the aetiology and clinical presentation of AS in Singapore, as well as patients' attitudes toward it. Our findings may facilitate the future planning and utilisation of resources to better manage these patients.Methods: 249 consecutive patients who underwent transthoracic echocardiography (from April 1999 to April 2008) and diagnosed with severe AS were assessed. Demographic and clinical data were collected, and patients' decisions on surgery were determined.Results: The mean patient age was 71 (range 23-98) years. 50.2% of patients were male. The commonest presenting symptom was dyspnoea, and 40 (16.0%) patients had coexistent atrial fibrillation. The aetiology of AS was degenerative in 216 (86.7%), rheumatic in 11 (4.4%) and related to a bicuspid valve in 22 (8.9%) patients. The average peak velocity across the aortic valve was 4.2 ± 0.8 m/s and the mean aortic valve area was 0.76 ± 0.13 cm2. The overall mean logistic EuroSCORE was 10.7 ± 12.3. 105 (42.2%) patients who were offered surgery refused. 87 (35%) deaths were seen during the follow-up period (mean duration 14.5 months), which also saw 68 (27%) patients undergo surgery and 86 (34%) patients hospitalised for heart failure.Conclusion: Degenerative AS was the commonest aetiology in this contemporary cohort of patients. Despite the known benefits of surgery, the refusal rate for surgery remained high. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
45. Total isovolumic time relates to exercise capacity in patients with transposition of the great arteries late after atrial switch procedures.
- Author
-
Tay, Edgar L. W., Gibson, Derek, Inuzuka, Ryo, Josen, Manjit, Alonso-Gonzalez, Rafael, Giannakoulas, Georgios, Li, Wei, Dimopoulos, Konstantinos, and Gatzoulis, Michael A.
- Published
- 2012
- Full Text
- View/download PDF
46. Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults With Congenital Heart Disease at Increased Mortality Risk in the Medium Term.
- Author
-
Inuzuka, Ryo, Diller, Gerhard-Paul, Borgia, Francesco, Benson, Leah, Tay, Edgar L. W., Alonso-Gonzalez, Rafael, Silva, Margarida, Charalambides, Menelaos, Swan, Lorna, Dimopoulos, Konstantinos, and Gatzoulis, Michael A.
- Published
- 2012
- Full Text
- View/download PDF
47. Transcatheter aortic valve implantation.
- Author
-
Gurvitch, Ronen, Tay, Edgar L., Wijesinghe, Namal, Ye, J., Nietlispach, Fabian, Wood, David A., Lichtenstein, Samuel, Cheung, Anson, and Webb, John G.
- Published
- 2011
- Full Text
- View/download PDF
48. Relation between combining evidence-based medications on mortality following myocardial infarction in patients with and without renal impairment.
- Author
-
Lik-Wui Tay, Edgar, Chan, Mark, Tan, Virlynn, Ling Ling Sim, Huay Cheem Tan, Yean Teng Lim, Kheng-Thye Ho, Boon-Lock Chia, Poo Sing Wong, and Tiong Cheng Yeo
- Published
- 2010
- Full Text
- View/download PDF
49. Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease.
- Author
-
Dimopoulos, Konstantinos, Diller, Gerhard-Paul, Petraco, Ricardo, Koltsida, Evdokia, Giannakoulas, Georgios, Tay, Edgar Lik, Best, Nicky, Piepoli, Massimo F., Francis, Darrel P., Poole-Wilson, Philip A., and Gatzoulis, Michael A.
- Abstract
Aims: We studied the prevalence of hyponatraemia and its prognostic implications in a large population of adult patients with congenital heart disease (ACHD). [ABSTRACT FROM PUBLISHER]
- Published
- 2010
- Full Text
- View/download PDF
50. Shortening of Median Door-to-Balloon Time in Primary Percutaneous Coronary Intervention in Singapore by Simple and Inexpensive Operational Measures: Clinical Practice Improvement Program.
- Author
-
CHI-HANG LEE, OOI, SHIRLEY B. S., TAY, EDGAR L., LOW, ADRIAN F., SWEE-GUAN TEO, LAU, CINDY, BEE-CHOO TAI, LIM, IRENE, LAM, SUSAN, ING-HAAN LIM, PING CHAI, and HUAY-CHEEM TAN
- Subjects
PERCUTANEOUS balloon valvuloplasty ,MYOCARDIAL infarction ,CARDIAC surgery patients ,CLINICAL medicine ,CARDIAC catheterization - Abstract
Background: Primary percutaneous coronary intervention is the standard reperfusion strategy for ST-segment elevation myocardial infarction in our center. We aimed to shorten the median door-to-balloon time from over 100 minutes to 90 minutes or less. Methods: We have been using three strategies since March 2007 to shorten the door-to-balloon time: (1) the intervention team is now activated by emergency department physicians (where previously it had been activated by coronary care unit); (2) all members of the intervention team have converted from using pagers to using cell phones; and (3) as soon as the intervention team is activated, patients are transferred immediately to the cardiac catheterization laboratory (where previously they had waited in the emergency department for the intervention team to arrive). An in-house physician and a nurse would stay with the patients before arrival of the intervention team. Results: During 12 months, 285 nontransfer patients (analyzed, n = 270) underwent primary PCI. The shortest monthly median door-to-balloon time was 59 minutes; the longest monthly median door-to-balloon time was 111 minutes. The overall median door-to-balloon time for the entire 12 months was 72 minutes. On a per-month basis, the median door-to-balloon time was 90 minutes or less in 10 of 12 months. On a per-patient basis, the median door-to-balloon time was 90 minutes or less in 182 patients (67.4%). There was 1 case (0.4%) of inappropriate activation by the emergency department. While waiting for the intervention team to convene, 1 patient (0.4%) deteriorated and had to be resuscitated in the cardiac catheterization laboratory. Conclusions: Improved health care delivery can be achieved by changing simple and inexpensive operational processes. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.